Bio-Techne Corporation
IT ˙ BIT ˙ US09073M1045
54,00 € 0,00 (0,00%)
2026-06-03
AKTIENPREIS
SecurityIT:1TECH / Bio-Techne Corporation
InstitutionTwinbeech Capital Lp
Latest Disclosed Ownership56,400 shares
Latest Disclosed Value $ 2,947,464
Twinbeech Capital Lp ownership in 1TECH / Bio-Techne Corporation

On May 15, 2026 - Twinbeech Capital Lp filed a 13F-HR form disclosing ownership of 56,400 shares of Bio-Techne Corporation (IT:1TECH) valued at $3,045,600 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2024 disclosing 0 shares of Bio-Techne Corporation. The current value of the position is $3,045,600 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIO-TECHNE COM 09073M104 56,400 56,400 2,947 0.3053
2024-11-14 2024-09-30 13F BIO-TECHNE COM 09073M104 0 -68,876 -100.00 0 -100.00
2024-08-14 2024-06-30 13F BIO-TECHNE COM 09073M104 68,876 -16,610 -19.43 4,935 -18.00 0.0971
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 85,486 85,486 6,017 0.1242
2024-02-14 2023-12-31 13F BIO-TECHNE COM 09073M104 0 -50,448 -100.00 0 -100.00
2023-11-14 2023-09-30 13F BIO-TECHNE COM 09073M104 50,448 50,448 3,434 0.0660
2023-08-14 2023-06-30 13F BIO-TECHNE COM 09073M104 0 -17,213 -100.00 0 -100.00
2023-05-15 2023-03-31 13F BIO-TECHNE COM 09073M104 17,213 17,213 1,277 0.0259
2023-02-14 2022-12-31 13F BIO-TECHNE COM 09073M104 0 -16,326 -100.00 0 -100.00
2022-11-14 2022-09-30 13F BIO-TECHNE COM 09073M104 16,326 -11,267 -40.83 4,637 -51.52 0.1223
2022-08-15 2022-06-30 13F BIO-TECHNE COM 09073M104 27,593 27,593 9,565 0.4279
2021-02-16 2020-12-31 13F BIO-TECHNE COM 09073M104 0 -2,754 -100.00 0 -100.00
2020-11-16 2020-09-30 13F BIO-TECHNE COM 09073M104 2,754 1,161 72.88 682 62.00 0.1479
2020-08-14 2020-06-30 13F BIO-TECHNE COM 09073M104 1,593 1,593 421 0.0923
2020-05-15 2020-03-31 13F BIO TECHNE COM 09073M104 0 -4,002 -100.00 0 -100.00
2020-02-14 2019-12-31 13F BIO TECHNE COM 09073M104 4,002 4,002 878 0.2542
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.